Basic Information
| RNALocate ID: | RLID:11000617 |
| RNA Symbol: | hsa-let-7d-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-let-7d |
| RNA ID: | miRBase:MIMAT0000065 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23056502 |
| Tissue/Cell Line: | Epidermal melanocytes (HEMa-LP) |
| Method: | Microarray |
| Description: | To distinguish miRNA signatures between melanoma cell-derived exosomes and normal melanocyte-derived exosomes, we compared the miRNome in A375 and HEMa-LP exosomes. We identified 130 miRNAs upregulated and 98 miRNAs downregulated in A375 versus HEMa-LP exosomes (Table S6). Data are collected from table S6. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001219 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001220 | Cytoplasm | Colon cancer cells | 20864815 |
| RLID:01001221 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001222 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001223 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001224 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001225 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001226 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001227 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001228 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001229 | Nucleus | HeLa cells | 22058130 |
| RLID:11000611 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000612 | Exosome | Human cervical carcinoma cell line (SiHa) | 25760330 |
| RLID:11000613 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11000614 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000615 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000616 | Exosome | Breast milk | 22211110 |
| RLID:11000618 | Exosome | Brain tissue | 23382797 |
| RLID:11000619 | Exosome | Plasma | 23663360 |
| RLID:11000620 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000621 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11000622 | Microvesicle | Plasma | 23077538 |
| RLID:11000623 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000624 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000625 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000004 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000264 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7d-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01210 |
| MNDR | hsa-let-7d-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01211 |
| MNDR | hsa-let-7d-5p | Oral squamous cell carcinoma | MNDR-E-MI-01212 |
| MNDR | hsa-let-7d-5p | Lymphoma | MNDR-E-MI-01213 |
| MNDR | hsa-let-7d-5p | Lymphoma non-hodgkin | MNDR-E-MI-01214 |
| MNDR | hsa-let-7d-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01215 |
| MNDR | hsa-let-7d-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01216 |
| MNDR | hsa-let-7d-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01217 |
| MNDR | hsa-let-7d-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01218 |
| MNDR | hsa-let-7d-5p | Her2-receptor positive breast cancer | MNDR-E-MI-01219 |
| MNDR | hsa-let-7d-5p | Breast cancer luminal | MNDR-E-MI-01220 |
| MNDR | hsa-let-7d-5p | Prostate cancer | MNDR-E-MI-01221 |
| MNDR | hsa-let-7d-5p | Gastric cancer | MNDR-E-MI-01222 |
| MNDR | hsa-let-7d-5p | Gastric lymphoma | MNDR-E-MI-01223 |
| MNDR | hsa-let-7d-5p | Alzheimer disease | MNDR-E-MI-01224 |
| MNDR | hsa-let-7d-5p | Dysautonomia familial | MNDR-E-MI-01225 |
| MNDR | hsa-let-7d-5p | Seizures | MNDR-E-MI-01226 |
| MNDR | hsa-let-7d-5p | Cardiovascular disease | MNDR-E-MI-01227 |
| MNDR | hsa-let-7d-5p | Carotid stenosis | MNDR-E-MI-01228 |
| MNDR | hsa-let-7d-5p | Lung cancer | MNDR-E-MI-01229 |
| MNDR | hsa-let-7d-5p | Metabolic syndrome x | MNDR-E-MI-01230 |
| MNDR | hsa-let-7d-5p | Parkinson disease | MNDR-E-MI-01231 |
| MNDR | hsa-let-7d-5p | Breast cancer | MNDR-E-MI-01232 |
| MNDR | hsa-let-7d-5p | Pancreatic cancer | MNDR-E-MI-01233 |
| MNDR | hsa-let-7d-5p | Melanoma | MNDR-E-MI-01234 |
| MNDR | hsa-let-7d-5p | Nephroblastoma | MNDR-E-MI-01235 |
| MNDR | hsa-let-7d-5p | Colon cancer | MNDR-E-MI-01236 |
| MNDR | hsa-let-7d-5p | Ischemic attack transient | MNDR-E-MI-01237 |
| MNDR | hsa-let-7d-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-01238 |
| MNDR | hsa-let-7d-5p | Familial ovarian cancer | MNDR-E-MI-01239 |
| MNDR | hsa-let-7d-5p | Prostate adenocarcinoma | MNDR-E-MI-01240 |
| MNDR | hsa-let-7d-5p | Carcinoma ductal breast | MNDR-E-MI-01241 |
| MNDR | hsa-let-7d-5p | Glioblastoma | MNDR-E-MI-01242 |
| MNDR | hsa-let-7d-5p | Glioma | MNDR-E-MI-01243 |
| MNDR | hsa-let-7d-5p | Chordoma | MNDR-E-MI-01244 |
| MNDR | hsa-let-7d-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-01245 |
| MNDR | hsa-let-7d-5p | Osteosarcoma | MNDR-E-MI-01246 |
| MNDR | hsa-let-7d-5p | Liposarcoma | MNDR-E-MI-01247 |
| MNDR | hsa-let-7d-5p | Meningioma | MNDR-E-MI-01248 |
| MNDR | hsa-let-7d-5p | Liver cancer | MNDR-E-MI-01249 |
| MNDR | hsa-let-7d-5p | Uterine cancer | MNDR-E-MI-01250 |
| MNDR | hsa-let-7d-5p | Cervical adenocarcinoma | MNDR-E-MI-01251 |
| MNDR | hsa-let-7d-5p | Lung squamous cell carcinoma | MNDR-E-MI-01252 |
| MNDR | hsa-let-7d-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-01253 |
| MNDR | hsa-let-7d-5p | Lung adenocarcinoma | MNDR-E-MI-01254 |
| MNDR | hsa-let-7d-5p | Adrenocortical cancer | MNDR-E-MI-01255 |
| MNDR | hsa-let-7d-5p | Thyroid carcinoma | MNDR-E-MI-01256 |
| MNDR | hsa-let-7d-5p | Tuberculosis | MNDR-E-MI-01257 |
| MNDR | hsa-let-7d-5p | Bladder urothelial carcinoma | MNDR-E-MI-01258 |
| MNDR | hsa-let-7d-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-01259 |
| MNDR | hsa-let-7d-5p | Renal clear cell carcinoma | MNDR-E-MI-01260 |
| MNDR | hsa-let-7d-5p | Biliary tract cancer | MNDR-E-MI-01261 |
| MNDR | hsa-let-7d-5p | Cholangiocarcinoma | MNDR-E-MI-01262 |
| MNDR | hsa-let-7d-5p | Esophageal cancer | MNDR-E-MI-01263 |
| MNDR | hsa-let-7d-5p | Lung small cell carcinoma | MNDR-E-MI-01264 |
| MNDR | hsa-let-7d-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-01265 |
| MNDR | hsa-let-7d-5p | Fibromyalgia | MNDR-E-MI-01266 |
| MNDR | hsa-let-7d-5p | Adenoma | MNDR-E-MI-01267 |
| MNDR | hsa-let-7d-5p | Breast invasive carcinoma | MNDR-E-MI-01268 |
| MNDR | hsa-let-7d-5p | Early hepatocellular carcinoma | MNDR-E-MI-01269 |
| MNDR | hsa-let-7d-5p | Familiar ovarian carcinoma | MNDR-E-MI-01270 |
| MNDR | hsa-let-7d-5p | B-cell lymphoma | MNDR-E-MI-01271 |
| MNDR | hsa-let-7d-5p | Rheumatoid arthritis | MNDR-E-MI-01272 |
| MNDR | hsa-let-7d-5p | T-cell leukemia | MNDR-E-MI-01273 |
| MNDR | hsa-let-7d-5p | Retinoblastoma | MNDR-E-MI-01274 |
| MNDR | hsa-let-7d-5p | Neuroblastoma | MNDR-E-MI-01275 |
| MNDR | hsa-let-7d-5p | Hodgkin lymphoma | MNDR-E-MI-01276 |
| MNDR | hsa-let-7d-5p | Burkitt lymphoma | MNDR-E-MI-01277 |
| MNDR | hsa-let-7d-5p | Tonsil cancer | MNDR-E-MI-01278 |
| MNDR | hsa-let-7d-5p | Acute myelocytic leukemia | MNDR-E-MI-01279 |
| MNDR | hsa-let-7d-5p | Colorectal cancer | MNDR-E-MI-01280 |
| MNDR | hsa-let-7d-5p | Nasopharynx carcinoma | MNDR-E-MI-01281 |
| MNDR | hsa-let-7d-5p | Multiple myeloma | MNDR-E-MI-01282 |
| MNDR | hsa-let-7d-5p | Nasopharyngeal cancer | MNDR-E-MI-01283 |
| MNDR | hsa-let-7d-5p | Prostatic neoplasms | MNDR-E-MI-01284 |
| MNDR | hsa-let-7d-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-01285 |
| MNDR | hsa-let-7d-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-01286 |
| MNDR | hsa-let-7d-5p | Breast cancer her3+ negative | MNDR-E-MI-01287 |
| MNDR | hsa-let-7d-5p | High grade dysplastic nodule | MNDR-E-MI-01288 |
| MNDR | hsa-let-7d-5p | Tubulovillous adenoma | MNDR-E-MI-01289 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABT1 | Homo sapiens | RR00027895 |
TOP